Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
bispecific antibody drug conjugate | 1.38 | 0.6 | 2768 | 23 | 34 |
bispecific | 0.56 | 0.5 | 769 | 3 | 10 |
antibody | 1.73 | 0.6 | 21 | 18 | 8 |
drug | 0.28 | 0.7 | 653 | 49 | 4 |
conjugate | 0.19 | 1 | 9348 | 91 | 9 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
bispecific antibody drug conjugate | 0.78 | 1 | 9759 | 96 |
what is a bispecific antibody | 0.93 | 0.2 | 1482 | 56 |
bispecific antibodies and their applications | 1.69 | 0.1 | 7501 | 82 |
antibody drug conjugate the biological | 0.17 | 0.7 | 9993 | 16 |
bispecific antibodies in clinical trials | 1.19 | 0.9 | 2673 | 52 |
bispecific monoclonal antibody drugs | 0.33 | 0.6 | 9997 | 61 |
antibody drug conjugate fda | 0.63 | 0.4 | 8080 | 93 |
bispecific antibody mechanism of action | 1.31 | 0.9 | 1063 | 79 |
fda approved bispecific antibody drugs | 1.91 | 0.9 | 304 | 88 |
list of bispecific antibodies | 0.8 | 0.1 | 843 | 38 |
bispecific antibodies in oncology | 0.73 | 1 | 9393 | 31 |
mispair in a therapeutic bispecific antibody | 1.26 | 0.2 | 6287 | 70 |
bispecific and trispecific antibodies | 1.1 | 0.5 | 4086 | 43 |
the making of bispecific antibodies | 0.39 | 0.4 | 5376 | 81 |
pharmacokinetics of bispecific antibodies | 0.89 | 1 | 7683 | 71 |
types of bispecific antibodies | 1.39 | 0.3 | 2217 | 44 |
list of approved bispecific antibodies | 1.17 | 0.1 | 2199 | 68 |
bispecific antibodies approved by fda | 1.02 | 0.9 | 1339 | 90 |